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Comparison of Radial Artery and Saphenous Vein Composite 
Y Grafts during Off-pump Coronary Artery Bypass
Jin-Hong Wi, M.D., Hyun-Chel Joo, M.D., Young-Nam Youn, M.D., Ph.D., 
Suk-Won Song, M.D., Ph.D., Tae Hoon Kim, M.D., Kyung-Jong Yoo, M.D., Ph.D.
Background: The safety and efficacy of arterial composite grafts for total arterial revascularization have been 
demonstrated. The saphenous vein (SV) is a widely used graft because of its accessibility, sufficient length, and 
ease of manipulation. Our aim was to compare mid-term outcomes of saphenous vein Y-grafts with radial artery 
Y-grafts joined by anastomosis to the left internal thoracic artery. Materials and Methods: Records of off-pump 
coronary artery bypass grafting with composite Y-grafts based on the left internal thoracic artery technique in 552 
patients were analyzed retrospectively. After propensity score matching, 79 radial arterial (RA) composite grafts (RA 
group) and 79 saphenous vein composite grafts (SV group) were compared. The duration of mean follow-up was 
24.6±14.6 months (range, 1 to 55 months). Results: There were no differences in surgical mortality, all-cause mor-
tality, or morbidity among the groups. Rates of 4-year survival were 91.7% and 96.3% in the RA and SV groups, 
respectively (p=0.519). The coronary reintervention-free survival rate and freedom from major adverse cardiovascular 
or cerebrovascular events were similar in the two groups (p=0.685, p=0.564). Conclusion: Construction of compo-
site Y-grafts using the radial artery or saphenous vein showed similar mid-term results. Long-term follow-up and 
randomized trials will be needed to confirm our present conclusions.
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INTRODUCTION
The choice of conduit for coronary artery bypass grafting 
has always been an issue important to cardiac surgeons who 
perform coronary artery bypass graft (CABG) surgery. The 
use of a left internal thoracic artery (LITA) graft has become 
the ‘gold standard’ following the Cleveland Clinic group re-
port that an internal thoracic artery (ITA) graft to the left an-
terior descending (LAD) artery was better than a vein graft 
with regard to survival and preventing ischemic events [1]. 
The excellent outcomes associated with ITA graft have led 
several groups to pursue arterial composite grafts for total ar-
terial revascularization based on the ITA graft as the pre-
ferred approach [2-5].
There have been only a few studies, of small sample sizes, 
reporting the results of CABG using the saphenous vein (SV) 
as a composite graft, and this vein composite graft is still 
controversial [6-9]. However, the SV has remained the most 
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Table 1. Preoperative characteristics and risk factors of the study patients
Variable
Entire study group (n=554) Propensity-matched pairs (n=158)
RA group SV group p-value RA group SV group p-value
Patients (n)
Age
Female
Body mass index
Diabetes mellitus
Dyslipidemia
Chronic renal failure
Hypertension
Chronic lung disease
Old cerebrovascular accident
PAOD
PTCA
NSTEMI/UA
IABP
Inotrope
Atrial fibrillation
NYHA≥3
left main disease
Left ventricular ejection fraction
Mitral regurgitation＞2
458
64.2±9.4
111 (24.2)
24.8±3.3
174 (38)
168 (36.7)
 35 (7.6)
325 (71.0)
  7 (1.5)
 46 (10.0)
 29 (6.3)
 88 (19.2)
225 (49.1)
  1 (0.2)
  4 (0.9)
  9 (2.0)
 46 (10.0)
112 (24.5)
57.1±14.2
 10 (2.2)
94
69.9±6.7
29 (30.9)
23.7±2.5
53 (56.4)
34 (36.2)
14 (14.9)
78 (83.0)
 4 (4.3)
19 (20.2)
11 (11.7)
18 (19.1)
53 (56.4)
 2 (2.1)
 4 (4.3)
 8 (8.5)
23 (24.5)
21 (22.3)
52.9±13.8
 4 (4.3)
＜0.001
0.179
0.002
0.001
0.925
0.024
0.017
0.051
0.005
0.067
0.988
0.200
0.022
0.013
0.001
＜0.001
0.816
0.009
0.245
79
69.6±5.7
28 (35.4)
24.3±2.9
43 (54.4)
25 (31.6)
10 (12.7)
67 (84.8)
 2 (2.5)
17 (21.5)
 7 (8.9)
16 (20.3)
43 (54.4)
 0 (0)
 4 (5.1)
 7 (8.9)
13 (16.5)
16 (20.3)
54.5±15.7
 2 (2.5)
79
69.7±6.4
25 (31.6)
24.0±2.6
43 (54.4)
27 (34.2)
12 (15.2)
65 (82.3)
 3 (3.8)
15 (19.0)
 8 (10.1)
15 (19.0)
44 (55.7)
 0 (0)
 2 (2.5)
 4 (5.1)
16 (20.3)
17 (21.5)
54.5±13.0
 4 (5.1)
0.954
0.613
0.446
1.000
0.735
0.646
0.668
0.649
0.692
0.786
0.841
0.873
1.000
0.405
0.348
0.538
0.845
0.991
0.405
Values are presented as mean±standard deviation or number (%).
RA, radial artery; SV, saphenous vein; PAOD, peripheral artery occlusive disease; PTCA, percutaneous transluminal coronary angio-
plasty; NSTEMI, non-ST elevation myocardial infarction; UA, unstable angina; NYHA, New York Heart Association.
widely used graft because of its accessibility, sufficient length, 
and ease of use. For patients with a diffusely atherosclerotic 
ascending aorta, SV composite Y-grafts may be necessary, 
particularly when there is some contraindication to the use of 
radial arterial (RA) grafts and LITA target vessels (mainly 
LAD artery) and severe (＞70%) stenosis.
The goal of this study was to compare the clinical out-
comes in two off-pump coronary artery bypass (OPCAB) 
groups that received either a pedicled RA composite graft or 
an SV composite graft to the LITA.
MATERIALS AND METHODS
1) Patient characteristics
Among the 1,181 patients who underwent isolated CABG 
at the Severance Cardiovascular Center of Yonsei University 
Health System in Korea between January 2008 and July 
2012, OPCAB was performed in 1,158 cases (98.1%). 
Among those, 552 patients (47.7%) who underwent elective 
OPCAB using composite Y-grafts anastomosed to the LITA 
entered this study. Patients undergoing an emergency oper-
ation or LITA anastomosis to target coronary vessels other 
than the LAD were excluded. Also, patients who required 
multiple composite Y-grafts (double or triple Y-graft) or ex-
tension of a graft were also excluded from this study. A 
pedicled RA (n=458) or SV (n=94) graft was joined by anas-
tomosis to the side of the LITA to construct a composite 
Y-graft. Propensity-score matching was used to balance the 
distribution of baseline risk factors between the patients re-
ceiving RA versus SV composite grafts. From those results, 
79 cases were selected for inclusion in the RA group and 79 
in the SV group. The characteristics of the study population 
before and after propensity matching analysis are summarized 
in Table 1.
2) Grafting strategy
The use of RA versus SV composite grafting was not ran-
dom; rather, it was decided according to the surgeon’s prefer-
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ence, the patient’s underlying condition, presence and degree 
of stenosis, and size of the target vessel. RA was a preferred 
composite Y-graft whenever possible for revascularization. 
However, in cases of atherosclerotic change in the RA graft, 
a positive Allen’s test, or severe peripheral artery occlusive 
disease, or particularly when there was severe (＞70%) steno-
sis of the LITA target vessels (mainly the LAD artery), an 
SV graft was used. We usually harvested the SV from the 
calf instead of the thigh to secure a vessel with small caliber 
to reduce flow steal and size discrepancy. Because the aver-
age pedicled RA graft length was 18 to 20 cm, a third graft 
was needed in some patients with three-vessel coronary disease. 
We usually used the SV as a third graft, as it is long enough 
to revascularize all the diseased territories when used as a 
free graft proximally anastomosed to the ascending aorta.
3) Surgical technique
OPCAB was performed as previously described [10]. Gene-
ral endotracheal anesthesia with continuous Swan-Ganz cathe-
ter monitoring, transesophageal echocardiography, and arterial 
pressure monitoring was used. All of the operations were per-
formed by the off-pump method via a full sternotomy incision. 
The LITA was used in all of the patients, and the RA, SV, 
right ITA, or right gastroepiploic artery was used if necessary. 
Harvest of the LITA was performed by a semi-skeletonized 
method using very low voltage unipolar electrocautery. He-
parin with papaverine was used to avoid vasospasm of the 
LITA. At the same time, the RA or SV was harvested by us-
ing an open technique. The RA or SV was exposed by a lon-
gitudinal incision and then all of the visible side branches 
were ligated. The SV was isolated, together with a pedicle of 
surrounding fatty tissue (no-touch technique). After removal, 
the excised SV or RA tissue was stored in heparinized blood, 
and a calcium channel blocker (diltiazem) was used to pre-
vent spasm of the RA during the operation. Heparin was giv-
en at a dose of 100 U/kg to achieve a target activated clot-
ting time of at least 300 seconds during the operation. For 
cardiac stabilization and displacement, we used an Octopus 
tissue stabilizer and Starfish heart positioner (Medtronic, Mi-
nneapolis, MN, USA) during construction of the anastomosis. 
An intracoronary shunt was mainly used for the LAD anasto-
mosis, and the proximal snaring technique with a silicone 
elastomer was used for anastomosis of other left coronary ar-
tery system vessels. For right coronary anastomosis, an intra-
coronary shunt was usually used for the main right coronary 
artery (RCA), and the proximal snaring technique was used 
for the posterior descending or posterolateral artery. To re-
move blood from the sites of arteriotomy, a combination of a 
carbon dioxide blower and irrigation with warm saline was 
used. Before the sternum was closed, the LITA graft was 
wrapped in thymic tissue to prevent injury during reoperation.
4) Data collection
Preoperative and perioperative data were collected retro-
spectively from the cardiac research databases at the 
Severance Cardiovascular Center of Yonsei University Health 
System in Korea. Follow-up data were obtained by reviewing 
hospital charts, telephone interviews, and searching the 
National Death Index. The collection of mid-term outcomes 
was complete in 90.1% of the patients. The mean follow-up 
duration was 24.6±14.6 months (range, 1 to 55 months).
5) Mid-term outcome assessment
Mid-term outcomes were assessed by all-cause mortality, 
reintervention, major adverse cardiac and cerebrovascular 
events (MACCEs), and morbidity. MACCEs were defined as 
any of the following: death from any cause, nonfatal my-
ocardial infarction, reintervention, or stroke. Myocardial in-
farction was defined as new onset of wall motion abnormal-
ity, creatine kinase MB isoenzyme elevation with appearance 
of new Q waves, or ST segment elevation of more than 2 
mm on electrocardiogram. Reintervention was defined as per-
cutaneous coronary intervention after surgery or redo coro-
nary bypass surgery.
6) Statistical analysis
For analysis of characteristics between the unmatched 
groups, continuous variables were compared using the t-test, 
and categorical variables were compared using the χ2 or 
Fisher’s exact test. To correct for the effect of non-random-
ization and selection bias in this retrospective study, propen-
sity score matching analysis was done. To produce propensity 
scores, we used logistic regression analysis of various pre-
operative variables. To analyze the differences between the 
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Table 2. Number of distal anastomoses
Entire study group (n=552) Propensity-matched pairs (n=158)
RA group SV group p-value RA group SV group p-value
Patients (n)
Total distal anastomoses per patient
Composite graft distal anastomoses
Free graft distal anastomoses
LAD territory
LCX territory
RCA territory
458
3.23±0.76
1.97±0.71
0.28±0.60
1.36±0.51
1.01±0.60
0.91±1.26
94
3.17±0.63
1.97±0.71
0.21±0.51
1.31±0.46
1.03±0.50
0.81±0.51
0.061
0.987
0.328
0.323
0.751
0.460
79
3.10±0.69
1.97±0.68
0.14±0.42
1.34±0.20
0.95±0.62
0.78±0.52
79
3.16±0.65
1.97±0.70
0.20±0.49
1.27±0.45
1.01±0.52
0.87±0.49
0.556
1.000
0.401
0.276
0.479
0.310
Values are presented as mean±standard deviation.
RA, radial artery; SV, saphenous vein; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary 
artery.
matched groups, means were compared using a paired 
Student’s t-test, and frequencies were analyzed by McNemar’s 
test. Overall survival, MACCEs, and coronary reintervention- 
free survival rate curves were estimated by the Kaplan-Meier 
method. Differences between curves were compared using the 
log-rank test. In all statistical tests, statistical significance was 
defined as a two-tailed p-value of less than 0.05. Statistical 
analysis was performed with IBM SPSS ver. 19.0 (IBM Co., 
Armonk, NY, USA). All of the results in the paper are ex-
pressed as mean±standard deviation, and a probability value 
less than 0.05 was considered statistically significant.
RESULTS
1) Patient characteristics
After propensity score matching, the demographics of the 
RA and SV groups were found to be similar with respect to 
age, gender (proportion of females), body mass index, dia-
betes mellitus, dyslipidemia, chronic renal failure, hyper-
tension, chronic lung disease, previous history of stroke, pe-
ripheral arterial occlusive disease, prior percutaneous coronary 
intervention, non-ST elevation myocardial infarction/unstable 
angina, intra-aortic balloon pump, inotropic agents, atrial fi-
brillation, New York Heart Association functional class, left 
main coronary artery disease, echocardiographic left ven-
tricular ejection fraction, and higher than grade two mitral 
regurgitation. From these covariates, a propensity score was 
calculated for each patient. Each patient in the RA group was 
matched 1:1 with a patient in the SV group. From this 
matching analysis, 79 patients in each group were selected 
for final analysis. The baseline characteristics of the RA and 
SV groups are shown in Table 1.
2) Surgical data
 The average number of distal anastomoses per patient was 
similar in the RA and SV groups (3.10±0.69 vs. 3.16±0.65; 
p=0.556). The average number of distal anastomoses per 
Y-graft (1.97±0.68 vs. 1.97±0.70; p=1.000) and the average 
number of distal anastomoses per patient using a free graft 
proximally anastomosed to the ascending aorta (0.14±0.42 vs. 
0.20±0.49; 0.401) did not differ between the two groups. 
When the coronary arteries were classified according to the 
LAD, left circumflex artery, and RCA regions, the number of 
distal anastomoses per region did not differ between the two 
groups (Table 2).
3) Surgical and mid-term clinical results
The surgical mortality was 1.27% (1/79) in the RA group, 
and this value was not significantly different than 0% in the 
SV group. There were no significant differences in the in-
cidence of postoperative morbidities, such as MACCEs, 
stroke, myocardial infarction, coronary reintervention, media-
stinitis, atrial fibrillation, low cardiac output syndrome, 
wound problems, respiratory complications, peripheral vas-
cular complications, or acute renal failure (Table 3). Two late 
mortalities occurred, one in the RA group (cancer-related 
death) and the other in the SV group (sudden death of un-
known origin). The 4-year survival rates were 91.7% and 
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Table 3. Comparison of clinical results
Variable
Entire study group (n=552) Propensity-matched pairs (n=158)
RA group SV group p-value RA group SV group p-value
Patients (n)
Early mortality
Myocardial infarction
Infection
Stroke
Pulmonary complication
Acute renal failure
Vascular complication
Atrial fibrillation
Wound complication
LCOS
Ventilator time (hr)
Late mortality
MACCEs
Reintervention
458
1 (0.2)
3 (0.7)
5 (1.1)
6 (3.8)
25 (5.5)
25 (5.5)
3 (0.7)
87 (19.0)
28 (6.1)
66 (14.4)
23.2±48.5
7 (1.5)
26 (5.7)
11 (2.4)
94
0 (0)
1 (1.1)
6 (6.4)
1 (1.1)
8 (8.5)
7 (7.4)
2 (2.1)
22 (23.4)
3 (3.2)
13 (13.8)
41.6±132.5
4 (4.3)
8 (8.5)
1 (1.1)
0.650
0.672
0.001
0.846
0.258
0.452
0.170
0.328
0.262
0.877
0.021
0.086
0.301
0.418
79
1 (1.3)
1 (1.3)
2 (2.5)
1 (1.3)
5 (6.3)
8 (10.1)
0 (0)
16 (20.3)
7 (8.9)
14 (17.7)
30.2±78.5
1 (1.3)
6 (7.6)
2 (2.5)
79
0 (0)
1 (1.3)
3 (3.8)
1 (1.3)
7 (8.9)
5 (6.3)
1 (1.3)
19 (24.1)
2 (2.5)
8 (10.1)
29.2±51.0
1 (1.3)
4 (5.1)
1 (1.3)
0.313
1.000
0.649
1.000
0.548
0.385
0.316
0.565
0.086
0.168
0.925
1.000
0.513
0.560
Values are presented as number (%) or mean±standard deviation.
RA, radial artery; SV, saphenous vein; LCOS, low cardiac output syndrome; MACCEs, major adverse cardiac and cerebrovascular 
events.
Fig. 1. Overall survival rate comparing radial artery (RA) group and saphenous vein (SV) group in (A) entire study groups (B) matched 
groups.
96.3% in the RA and SV groups, respectively (p=0.519) (Fig. 1). 
Three patients underwent coronary reintervention during fol-
low-up. Coronary reintervention-free survival rates at 4 years 
were 94.4% and 98.7% in the RA and SV groups, re-
spectively (p=0.685) (Fig. 2). Freedom from MACCEs at 4 
years was also similar in the two groups (p=0.564) (Fig. 3).
4) Early patency rates
Early postoperative coronary computed tomography angiog-
raphy (CTA) was performed before discharge (4 to 7 days af-
Jin-Hong Wi, et al
− 270 −
Fig. 3. MACCEs-free survival rate comparing radial artery (RA) group and saphenous vein (SV) group in (A) entire study groups (B) 
matched groups. MACCEs, major adverse cardiac and cerebrovascular events.
Fig. 2. Coronary reintervention-free survival rate comparing radial artery (RA) group and saphenous vein (SV) groups in (A) entire study 
groups (B) matched groups.
ter the operation) in 65.9% (364 of 552) of the patients (318 
of 458 in the RA group; 46 of 94 in the SV group) regard-
less of the patient’s anginal symptoms. Patients who died, re-
fused CTA evaluation, had limited financial resources, or had 
renal function impairment were excluded from CTA fol-
low-up. Early postoperative coronary CTA demonstrated a 
100% patency rate in both groups (Table 4).
DISCUSSION
The present study revealed two main findings. First, the 
mid-term clinical results were similar for RA and SV compo-
Composite Y Graft
− 271 −
Table 4. Comparison of early angio computed tomography patency rates
Entire study group (n=364) Propensity-matched pairs (n=87)
RA group (n=318) SV group (n=46) p-value RA group (n=48) SV group (n=39) p-value
Overall patency
In situ left internal thoracic artery
Y-composite
Free graft
1,025/1,030 (99.5)
315/318 (99.1)
611/613 (99.7)
103/103 (100)
149/149 (100)
46/46 (100)
92/92 (100)
12/12 (100)
0.446
0.589
0.698
1.000
151/151 (100)
48/48 (100)
97/97 (100)
7/7 (100)
126/126 (100)
39/39 (100)
78/78 (100)
10/10 (100)
1.000
1.000
1.000
1.000
Values are presented as number (%).
RA, radial artery; SV, saphenous vein.
site Y-grafts anastomosed to the LITA. Second, the early 
postoperative coronary CTA patency rates of the SV and RA 
groups were similar.
The safety and efficacy of composite grafts for total arte-
rial myocardial revascularization have been demonstrated in 
terms of clinical outcomes, angiographic patency, and my-
ocardial perfusion, although controversy still exists [2-5,11]. 
The expanded use of LITA in a Y configuration with another 
arterial conduit, such as an RA graft, which allows maximal 
arterial graft economy and sufficient length of the grafts, has 
been performed with excellent clinical results [12]. Indeed, 
this graft configuration allows the performance of complete 
myocardial revascularization with no more than two grafts. 
This method significantly increases the flow capacity of the 
in situ ITA [13]. In addition, it can avoid aortic manipulation 
and thereby reduces the risk of stroke during the operation. 
The incidence of postoperative stroke increases with increased 
levels of aortic manipulation. This is particularly true in eld-
erly patients, considering the high prevalence of moderate to 
severe atherosclerotic aortic disease.
However, CABG using the SV as a composite graft anasto-
mosed to in situ LITA represents an unusual type of 
procedure. Only a few studies conducted in a small number 
of patients have reported results of CABG using SV compo-
site grafts, and this graft configuration is controversial 
[6-8,14]. The SV graft may be regarded as a major ITA col-
lateral branch whose caliber is significantly larger than that of 
the main artery itself. Moreover, it is less reactive than all of 
the other arterial conduits and is likely to offer less resistance 
to flow. This situation can create the possibility of a sig-
nificant flow diversion from the ITA to the SV. Flow steal is 
even enhanced when the ITA is anastomosed to a coronary 
vessel with moderate (＜70%) stenosis [15-18]. Gaudino et 
al. [6] studied 25 patients in whom a saphenous vein graft 
(SVG) was implanted into the LITA. They found that the 
short-term patency of a composite Y ITA-SVG was sub-
optimal and markedly influenced by distal runoff and native 
flow competition. In fact, all cases of ITA malfunction were 
reported in the part of the ITA distal to the SVG anastomosis 
and in the patients in whom the composite SVG was anasto-
mosed to the coronary arteries with less than 70% stenosis 
(p=0.02).
However, SVG is still the most widely used graft because 
of its accessibility, sufficient length, and ease of use. 
Hayward et al. [19] found no clinical benefit of RA over SV 
graft at 6 years of follow-up. Glineur et al. [9] evaluated the 
hemodynamic characteristics of 17 composite Y-grafts of the 
LITA with either the free right ITA or SVG bypassed to the 
circumflex territory 6 months after the operation. They found 
that composite Y-grafts with the SV or right ITA allow sim-
ilar and adequate reperfusion of the left system, with minimal 
resistance to maximal flow and an even distribution of flow 
in both distal branches.
In the present study, RA was preferred for use as a com-
posite Y-graft for the LITA whenever possible for revascular-
ization. We performed CABG using the SV as a composite 
graft for the LITA only in case of patients with a diffusely 
atherosclerotic ascending aorta, particularly when there was 
some contraindication to the RA grafts and LITA target ves-
sels (mainly LAD artery) with severe (＞70%) stenosis. We 
also usually harvested the SV from the calf instead of the 
thigh to secure an SV with small caliber to reduce the flow 
steal and size discrepancy.
In the current study, we did not observe any disadvantage 
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of SV composite grafting relative to that with RA. However, 
our results are too limited to assert that the clinical results of 
SV grafting can actually be expected to be similar to those of 
RA grafting. Studies with longer follow-up may in fact en-
counter different results. However, this study at least leads to 
the conclusion that SV composite grafts are similar to RA 
composite grafts anastomosed to the LITA with respect to the 
4-year survival rate and occurrence of MACCEs.
There are some limitations to this study. First, it is retro-
spective, non-randomized, and based on a single-center 
experience. Second, the data were obtained from two sur-
geons, so bias associated with the surgeons may play an im-
portant role in our findings. However, the surgeons were both 
highly experienced, mainly performed off-pump CABG, and 
used very similar methods for grafting, and this minimizes 
some of that bias. Third, our preferred strategy was total arte-
rial revascularization, and the SV was used as an alternative 
graft when an RA graft was not available. This might have 
influenced the surgical results as a confounding variable, even 
though there were no differences in the demographic data af-
ter propensity score matching. Fourth, the number of patients 
and mortality and morbidity rates may not have been suffi-
cient to achieve adequate outcomes after statistical analysis in 
order to conclusively decide the issue of the preferred graft 
vessel.
In conclusion, we observed that mid-term clinical results 
were similar between RA and SV composite Y-grafts anasto-
mosed to the LITA. However, long-term clinical and angio-
graphic data might be necessary to draw a definite conclusion 
regarding the safety and efficacy of SV composite grafts.
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